← Back to Clinical Trials
Recruiting NCT06485895

Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis

Trial Parameters

Condition TUBERCULOSIS
Sponsor Assistance Publique Hopitaux De Marseille
Study Type INTERVENTIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-07-30
Completion 2027-07-30
Interventions
test IGRATEST QUATIFERON TB Gold Plus

Brief Summary

Methodology This is a single-center study carried out as part of routine patient care. The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.

Eligibility Criteria

Inclusion Criteria: * Individual at least 18 years of age * Patient presenting for treatment of tuberculosis disease * Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test. * Informed patient who has not expressed opposition to participating in the study. French-speaking patient with unambiguous understanding of oral and written instructions. Exclusion Criteria: Persons in a period of exclusion from another study * Pregnant, parturient or breast-feeding women; * Person deprived of liberty by judicial or administrative decision

Related Trials